Advertisement
U.S. markets open in 8 hours 58 minutes

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.8500-0.0102 (-1.19%)
At close: 04:00PM EDT
0.8590 +0.01 (+1.06%)
After hours: 07:30PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close0.8602
Open0.8310
Bid0.8003 x 1100
Ask0.8455 x 1400
Day's Range0.8310 - 0.8597
52 Week Range0.4100 - 1.1200
Volume492,243
Avg. Volume1,643,645
Market Cap156.075M
Beta (5Y Monthly)0.86
PE Ratio (TTM)N/A
EPS (TTM)-1.4500
Earnings DateMay 07, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NKTR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Nektar Therapeutics
    NKTR: Lowering target price to $0.58NEKTAR THERAPEUTICS has an Investment Rating of SELL; a target price of $0.584000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    last yearArgus Research
View more